The Value of Systematic Reviews in Estimating the Cost and Barriers to Translation in Tissue Engineering

被引:11
作者
Cousin, Margot A. [1 ]
Greenberg, Alexandra J. [1 ]
Koep, Tyler H. [1 ]
Angius, Diana [2 ]
Yaszemski, Michael J. [3 ]
Spinner, Robert J. [2 ]
Windebank, Anthony J. [1 ,4 ]
机构
[1] Mayo Clin, Ctr Clin & Translat Sci, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Neurol Surg, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA
关键词
systematic review; economics; translation; peripheral nerve; scaffold;
D O I
10.1089/ten.teb.2016.0060
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Little quantitative data exist concerning barriers that impede translation from bench to bedside. We systematically reviewed synthetic or biosynthetic polymer nerve scaffolds for peripheral nerve repair to study a defined research area that is beyond the discovery phase and has potential for clinical application. Using electronic and manual search methods, we identified published English language articles, where scaffolds were tested in preclinical animal models. A systematic review of these 416 reports estimated all costs related to the use of animals, surgery, and evaluation methods. The research studied 17 different nerves in eight animal species, with use of 65 evaluation methods at an estimated cost of $61,264,910 for the preclinical studies. A total of 127 surveys were sent to authors, of whom 12 could not be accessed electronically and 45 (39%) responded. Major causes for failure to translate included lack of a commercial partner, insufficient financial resources, a research program not involved in translation, and lack of expertise in regulatory affairs. This review emphasizes the urgent need for standardization of preclinical models and the need to establish better collaboration between laboratory investigators, clinicians, and the companies involved in commercialization. It identifies important areas for education of future investigators in the process of translation from discovery to improved health such as those funded by the National Institutes of Health Clinical and Translational Science Awards.
引用
收藏
页码:430 / 437
页数:8
相关论文
共 18 条
  • [1] Agency for Healthcare Research and Quality U.S. Department of Health and Human Services, 2012, EFF HLTH CAR PROGR W
  • [2] Altevogt BM, 2011, CHIMPANZEES IN BIOMEDICAL AND BEHAVIORAL RESEARCH: ASSESSING THE NECESSITY, P1
  • [3] A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds
    Angius, Diana
    Wang, Huan
    Spinner, Robert J.
    Gutierrez-Cotto, Yearim
    Yaszemski, Michael J.
    Windebank, Anthony J.
    [J]. BIOMATERIALS, 2012, 33 (32) : 8034 - 8039
  • [4] [Anonymous], 2012, ENG STRAT OPP CHALL
  • [5] Balas E.A., 2000, YB MED INFORM, V65
  • [6] Translational research: Crossing the valley of death
    Butler, Declan
    [J]. NATURE, 2008, 453 (7197) : 840 - 842
  • [7] Collins F.S., SCI TRANSL MED, V3
  • [8] DiMasi JA, 2005, J HEALTH ECON, V24, P1034, DOI 10.1016/j.jhealeco.2005.07.002
  • [9] Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2005, 24 (05) : 1049 - 1053
  • [10] The price of innovation: new estimates of drug development costs
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 151 - 185